C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 53 000 KRW 0.76% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
Celltrion Pharm Inc?
Write Note

Celltrion Pharm Inc
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celltrion Pharm Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
C
Celltrion Pharm Inc
KOSDAQ:068760
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Non-Reccuring Items
â‚©46.8B
CAGR 3-Years
N/A
CAGR 5-Years
55%
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Non-Reccuring Items
â‚©5.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Non-Reccuring Items
â‚©17B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Non-Reccuring Items
-â‚©7.6B
CAGR 3-Years
N/A
CAGR 5-Years
-12%
CAGR 10-Years
-4%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Celltrion Pharm Inc
Glance View

Market Cap
2.2T KRW
Industry
Pharmaceuticals

Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 841 full-time employees. The company went IPO on 2006-02-03. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. The company also provides ethical drugs and over-the-counter (OTC) drugs. The firm distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.

Intrinsic Value
17 592.39 KRW
Overvaluation 67%
Intrinsic Value
Price
C

See Also

Back to Top